ArticleStatistics in medicine2025
A Seamless Design for the Combination of a Case-Control and a Cohort Diagnostic Accuracy Study.
Article in Statistics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In determining the accuracy of a new diagnostic test, often two steps are performed. In the first step, a case-control study is performed as an efficient but potentially biased design. In a second step, a population-based cohort study is performed as an unbiased but less efficient design. In order to accelerate diagnostic research, it has recently been suggested to combine the two designs in one seamless design. In this article, we present a more in-depth description of this idea. The seamless diagnostic accuracy study design is formally introduced by comparison with the traditional pathway, and the basic design decisions are discussed: A stopping rule and a stopping time. An appealing feature of the design is the possibility to ignore the seamless design in the final analysis, although part of the data is used already in an interim analysis. The justification for this strategy is provided by a large-scale simulation study. The simulation study suggests also that the risk of a loss of power due to using a seamless design can be limited by a reasonable choice of the futility boundaries, defining the stopping rule. We conclude that the seamless diagnostic accuracy study design seems to be ready to use. It promises to accelerate diagnostic research, in particular if population-based cohort studies can be started without great efforts and if the reference standard can be evaluated with little delay.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.